Skip to main content
. Author manuscript; available in PMC: 2015 Nov 19.
Published in final edited form as: J Immunotoxicol. 2012 Sep 7;10(1):59–66. doi: 10.3109/1547691X.2012.691124

Figure 4.

Figure 4

DMC exposure does not alter the serum IgM response to SRBC. Analysis of serum after a 28-day dermal exposure to DMC did not produce alternations in IgM response to SRBC. Bars represent mean fold-change (± SE) of six mice per group. Cyclophosphamide (CP) was included as the positive control.